The ultimate goal for researchers in the ESSENCE trial was to find the right balance of semaglutide to resolve the damage caused by fat buildup in the liver (steatohepatitis) while at the same time to reduce scarring (fibrosis)
Body fat and fat-free mass inter-relationships: Forbess theory revisited
Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH
The drug or matching placebo were given for 12 months and the primary endpoint, as shown below, was a motor score used by neurologists (Movement Disorder Scale-Unified Parkinsons Disease Rating Scale) MDS-UPDRS Part III)
Metabolic disorders and diffuse brain injury will usually have a generalized onset, whereas a discrete lesion in the brain tends to lead to partial-onset seizures
It has real health and financial implications